chart please, page-11

Exactly, I know it has some real assets, stolwyk, and always has done, so why stuff around with naturopathy which is likely at any time to undermine the credibility of what it is seriously trying to sell? Or at least branch it off into a different division.

I have been following NRT since 1997, and have had the impression that they will buy into anything going, without too much discrimination or strategy. They have become very good at playing the stock market game of key announcements, but they are never going to be a Pfizer or a Bayer because they are not serious.